Plasma ceramide (14:0) is regarded as the strongest predictor of insulin resistance in obesity and diabetes because its decreased level is negatively correlated with increased insulin sensitivity [59]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.